Introduction: Umbilical cord blood contains relatively abundant primitive CD34
INTRODUCTION
Hematopoietic stem cells (HSCs) are capable of self-renewal and differentiation into erythroid, myeloid, and lymphoid lineages (Mikkola et al. 2003) . T-cell lymphopoiesis is largely dependent on the presence of the thymus (Kakinuma et al. 2003; Sugimoto et al. 2002) . Generally, T-cell precursors migrate into the thymus from bone marrow and differentiate from CD4 + cell stages (Andersnon et al. 1994; Guidos et al. 1990 ).
The fate of most developing thymocytes is intrathymic death, either early through a failure of the surface T-cell receptor to be engaged by self MHC (positive selection) or later in a maturation process by which self-reactive thymocytes are eliminated (negative selection). Only 1-2% of total thymocytes are exported to the periphery after undergoing positive and negative selection (Deftos et al. 2000; Kappler et al. 1987; Kraft et al 1993; Su and Manley 2002; Swat et al. 1992 -CD4 + single-positive cells are thought to be mainly located in the outer cortex and to be blastic and cortisone sensitive (Guidos et al. 1990) . Kim et al. (Kim et al. 2005) found that OX40 signals from CD4 + CD3 -cells located in the outer T zone select proliferating Th2 effectors into the memory T cell pool. Lane et al. (Lane et al. 2005) thought that CD4 + CD3
cells have two functions: organizing lymphoid tissue during development and supporting T-cell help for B cells both during affinity maturation in germinal centers and for memory antibody responses. Their further research showed that CD4 + CD3 -cells act as a tether between the selecting T cells and the follicular dendrit-ic cells and thus play a role in segregating B and T cells in normal lymphoid tissue (Kim et al. 2007; Lane et al. 2005) .
The thymic epithelium is essential for the early T--cell differentiation of hematopoietic precursors as well as the terminal differentiation to mature T cells (Utsuyama et al. 2003) . A number of different cell types in the thymus play critical roles in the process of supporting T-cell differentiation, including MHC class II--positive thymic epithelial cells and mesenchymal cells. In general, T-cell differentiation depends on the complex three-dimensional structure of an intact thymic environment. However, it is not clear whether the differentiation from CD34 + cells toward T cells can be observed through the immature CD4 + CD8
-CD3 -cells. The experimental study of human T-cell lymphopoiesis has been largely limited to the use of the OP9 expressing the Notch ligand Delta-like 1 (OP9--DL1) SCID-hu mouse model (Galy et al. 1993) , murine and human thymic organ cultures (Rosenzweig et al. 1994; Yeoman et al. 1993) , and human thymic monolayers (Poznansky et al. 2000) . Zuniga-Pflucker demonstrated that retrovirally transduced DL1 Notch ligand to the OP9 bone marrow stromal cell line inhibited the development of B cells but favored the development of T cells from fetal liver-derived HSCs and CB-derived HSCs (La Motte-Mohs et al. 2005) . In previous studies, thymic stromal cell (TSC) monolayer culture systems provided a useful tool for studying the differentiation of human T lymphocytes. Umbilical cord blood is an alternative source of hematopoietic stem and progenitor cells. In this study we utilized TSC support systems which were based on fetal thymus organ culture as described by Jenkinson et al. (Jenkinson et al. 1982) and Kingstion et al. (Kingston et al. 1985) 
MATERIALS AND METHODS

Thymic organ culture
This study protocol was reviewed and approved by the ethics review committee of our hospital. Human thymus gland was removed from electively aborted fetuses of 18-20 weeks of gestation by aseptic operation in the department of Ob/Gyn of our hospital after the mother's informed consent was obtained. Thymic tissue was processed within 4 h of harvest. The thymic tissue was minced into small fragments, passed through a mesh sieve, and digested into a single-cell suspension by incubation in phosphate-buffered saline (PBS) containing 0.5 mg/ml of collagenase (Sigma, St. Louis, MO, USA) and 2 U/ml DNase I (Sigma) at 37°C for 60 min with frequent agitation. Typically, 1-10×10 8 cells were obtained per gland, with about 90% viability as assessed by trypan blue exclusion. The cell suspension was then washed twice in culture media (IMDM; Gibco, Grand Island, NY, USA) containing 10% heat-inactivated human AB serum (HABS) and glutamine (1 mM). Thymic stromal cultures were established using fresh cells in 24-well plates at a concentration of 10 6 cells per well in 2 ml of medium at 37°C in a humidified atmosphere of 5% CO 2 /95% air. After two day's culture, non-adherent cells were removed by washing twice with fresh medium. The monolayer was then incubated in culture media that was changed at least twice a week. Adherent cells were detached by trysin-EDTA (Gibco, Grand Island, NY, USA) after they reached confluence and seeded at 10 5 cells/well in 48-well plates (Costar, Cambridge, MA, USA) with IMDM containing 10% HABS and glutamine (1 mM). The second-passage TSCs were used as a feeder layer in the T-cell lymphopoiesis assay.
Purification of cord blood CD34 + cells
Umbilical cord blood was obtained from the Department of Ob/Gyn at our hospital after the mother's informed consent was obtained. Cord blood (50-100 ml) was collected in sterile bags containing 28 ml of citrate phosphate dextrose (Sigma) as anticoagulant, brought to the laboratory at room temperature, and processed within 6 h. Mononuclear cells (MNCs) were separated by density gradient centrifugation at 1300 rpm for 15 min at room temperature over Ficoll--Paque (Pharmacia Biotech Inc., Piscataway, NJ, USA). Interface cells were washed twice by mixing with 2 ml of buffer-PBS and centrifuging at 1500 rpm for 8 min at room temperature. The MNCs were resuspended in complete medium and cultured overnight at 37°C to remove adherent cells. Erythrocytes were removed by lysis with 0.15 M ammonium chloride.
Highly purified CD34 + cells were enriched from MNCs with two rounds of purification. First, MNCs were incubated with magnetic beads coated with anti--human CD34 antibody (QBEND/10, MACS, Bergisch Gladbach, Germany), then CD34 -cells were removed by washing three times with buffer-PBS in MACS. The highly purified CD34 + cells were collected according to the protocol described by the manufacturer. The collected CD34 + cells were again passed through another column to achieve a higher purity to ensure that the cells added to the TSCs were derived from CD34 + cells, not CD34 -cells. The human CD34 + cells purified from cord blood MNCs using Mini-MACS were further depleted of cells expressing the lymphoid markers CD2 or CD3 to minimize T-cell contamination.
Limiting dilution and T-cell lymphopoiesis assay
Immature and mature T cells were generated from the CD34 + cells using the previously established method of re-seeding subconfluent cultures (Rosenzweig et al. 2001) . The purified CD34 + cells were plated on the adherent TSCs by limiting-dilution analysis, which is used to estimate HSC activity. Four dilutions were used, with three replicate wells for each. A minimum of 50 CD34 + cells per well were plated in 1 ml of IMDM containing 10% HABS, 10 ng/ml recombinant human interleukin-12 (rhIL-12; Perpertech, USA), 30 ng/ml recombinant human Flt-3 ligand (rhFL; Perpertech, USA), 50 ng/ml recombinant human stem cell factor (rhSCF; Perpertech, USA), and 50 IU/ml rhIL-2 (Perpertech, USA) at 37°C in 5% CO 2 /95% air. The dilutions were chosen to be maximally informative after two weeks of incubation. The cytokine combination has been shown to promote CD34
+ cell expansion and T-cell differentiation (Mourcin et al. 2005; Nelson and Willerford 1998) . Half of the medium in each well was removed and replaced with fresh medium containing cytokines every 3-4 days. Immunophenotyping of the cultured cells was carried out with flow cytometry (XL-AD 2517, Beckman-coulter).
The T-cell subpopulation was detected by staining with fluorescein isothiocyanate (FITC)-labeled monoclonal antibody (mAB) against CD4 (CD4 FITC, BD Pharmingen), phycoerythrin (PE)-labeled mAB against CD8 (CD8 PE, BD Pharmingen), and phycoerythrincyanine 5 (PC5)-labeled mAB against CD3 (CD3 PC5, BC Pharmingen) and analyzed by flow cytometry at days 15, 18, 21, 24, 27, and 30 during the culture period. After being harvested by gentle aspiration and washed twice in PBS, the cells were stained in a final volume of 100 µl with the above antibodies. The isotype controls used were IgG1-FITC, IgG1-PE, and IgG1-PerCP, respectively. The stained samples were washed twice in PBS and flow cytometry analysis was performed immediately. System II Software or Cofit software was used for data analysis.
TSCs without CD34 + cells were cultured at the same time and harvested using trysin-EDTA at day 0 and day 15. These cells were stained with the same procedure and served as controls for the T-cell lymphopoiesis assay.
Statistical analysis
Comparisons were made using standard statistical tests. Results are presented as the mean ± standard deviation (SD). A p value <0.05 was considered significant differentiation. CD4 + CD8 -CD3 -cells were compared with other subsets using repeated measures analyses of variance. Statistical analyses were performed using CHISS (Chinese High Intellectualized Statistical Software) version 2004.
RESULTS
As reported by others (Sarun et al. 1998), TSCs from human thymus were isolated as a reliable feeder layer for T-cell lymphopoiesis in vitro. The TSCs were monitored daily. The cell clones could be seen on day 3 and + cord blood cells were detached by trysin-EDTA at day 0 and day 15. Cells were stained with CD3 PC5, CD4 FITC, and CD8 PE mABs. The result showed that the TSCs were negative for CD4, CD8, and CD3, thus excluding the possible contamination of CD3 -CD4 + CD8 -from TSCs.
became confluent on day 8. The TSCs were composed mainly of epithelial cells (60-90%). A typical TSC looked like a fibroblast. Flow cytometry analysis showed that the TSCs were negative for CD3, CD4, and CD8 (Fig. 1) . About 3-6×10 5 CD34 + cells were isolated from each cord blood unit and the purity of the isolated CD34 + cells ranged from 95 to 99%. When the cord blood CD34 + cells were cultured on a TSC layer in medium supplemented with IL-12, FL, SCF, and IL-2, they underwent T-cell lymphopoiesis in vitro in a manner that recapitulated T-cell ontogeny in vivo. The cell number increased rapidly. The cells were harvested at the indicated time points for phenotype analysis. After a two-week culture period, mainly CD4 + CD8 + (double-positive) immature T lymphocytes were detected. At the same time we found a small immature CD4
-cell subset (3.78±0.49%) (Fig. 2) . Then the proportion of immature CD4 + CD8 + T lymphocytes decreased with time, coincident with a gradual increase in mature T lymphocytes (Fig. 3) . To confirm that the immature and mature T cells were derived from cord blood CD34 + cells, we harvested and stained control TSCs at different time points and could not detect any T cells (either immature or mature) by flow cytometry analysis.
DISCUSSION
TSCs have been proven to be a valuable model in the study of sequential differentiation of murine, chicken, rhesus, and human thymocytes. In this study we observed that the highly purified cord blood CD34 + cells differentiated into T cells on TSCs after limiting dilution following a pattern that mirrors T-cell development in vivo. The T cells derived from this culture system have the phenotype of mature T cells. We can exclude the possibility that these T cells are residue T cells in the cord blood or arise from the TSCs based on the following facts. Firstly, two rounds of MACS were performed for the enrichment of CD34 + cells. Flow cytometry analysis confirmed that the purity of the CD34 cells was higher than 99% and residue T cells were less than 1%. Secondly, the number of CD34 + cells in each well was controlled by limiting dilution. As described above, the enriched CD34 + cells contained almost no CD34 -cells. Thirdly, we could not find any T cells in the control TSC-only culture, thus excluding the possibility that the immature and mature T cells might originate from residual mature thymocytes in the TSCs. Most importantly, this experiment was repeated a total of five times by different researchers and the same result was achieved each time.
It was previously reported that T-cell precursors migrating from the bone marrow can differentiate from 
CD3
-T lymphocytes for their BJ gene repertoires and found the overall BJ gene repertoire was developed before antigenic selection, which was then further modified by thymic selection and peripheral stimulation.
Our results also demonstrated that human CD4 + CD8 -CD3 -cells derived from CD34 + cells in vitro may be an immature subset during T-cell lymphopoiesis. Kraft et al. (Kraft et al. 1993 ) described this CD4 + CD8 -CD3 -cell population, which represents an alternative intrathymic T-cell precursor, as a monocytic population. Gardner et al. (Gardner et al. 1998) (Kim et al. 2007 ).
In conclusion, we showed that CD4 + CD8 -CD3 -cells can be derived from highly purified CD34 + cells on TSCs during T-cell lymphopoiesis in vitro. The characteristics and function of this cell subpopulation deserve further study. 
